Guangdong Taienkang Pharmaceutical Co., Ltd. (SHE:301263)
29.43
-0.09 (-0.30%)
At close: Mar 9, 2026
SHE:301263 Market Cap
SHE:301263 has a market cap or net worth of 12.46 billion as of March 9, 2026. Its market cap has increased by 78.26% in one year.
Market Cap
12.46B
Enterprise Value
12.31B
Revenue
674.49M
Ranking
n/a
PE Ratio
535.17
Stock Price
29.43
Market Cap Chart
Since March 29, 2022, SHE:301263's market cap has increased from 8.26B to 12.46B, an increase of 50.91%. That is a compound annual growth rate of 10.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 12.46B | 1.52% |
| Dec 31, 2025 | 12.28B | 93.40% |
| Dec 31, 2024 | 6.35B | -8.63% |
| Dec 29, 2023 | 6.95B | -9.56% |
| Dec 30, 2022 | 7.68B | -6.98% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zhejiang Jingxin Pharmaceutical | 12.80B |
| Henan Lingrui Pharmaceutical | 12.11B |
| Zhejiang Hisun Pharmaceutical | 12.06B |
| Zhejiang Hisoar Pharmaceutical | 11.87B |
| Shanghai Haoyuan Chemexpress | 13.30B |
| Shenzhen Chipscreen Biosciences | 13.49B |
| Beijing Aosaikang Pharmaceutical | 13.58B |
| Porton Pharma Solutions | 11.46B |